gms | German Medical Science

27th German Cancer Congress Berlin 2006

German Cancer Society (Frankfurt/M.)

22. - 26.03.2006, Berlin

Leukemia / Lymphoma / Stem Cell Transplantation

Meeting Abstract (OP101)

Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography

Wuchter P, Kasper B, Lehnert T, Ho AD, Haberkorn U, Egerer G
[Full Text]
Meeting Abstract (OP102)

First line therapy with Fludarabine (F) versus Chlorambucil (CLB) in elderly patients (PTS) with advanced CLL: results of a multicentre phase III study (CLL5 protocol) of the German CLL Study Group (GCLLSG)

Eichhorst B, Busch R, Stauch M, Bergmann M, Ritgen M, Kranzhöfer N, Rohrberg R, Söling U, Burkhard O, Emmerich B, Brittinger G, Hallek M
[Full Text]
Meeting Abstract (OP103)

The AML1-ETO Fusion Gene and the FLT3 Length Mutation Collaborate in Inducing Acute Leukemia in a Murine Bone Marrow Transplantation Model

Scheßl C, Rawat VPS, Cusan M, Deshpande A, Kohl TM, Rosten PM, Spiekermann K, Humphries RK, Schnittger S, Kern W, Hiddemann W, Quintanilla-Martinez L
[Full Text]
Meeting Abstract (OP104)

Diagnosis of Burkitt’s lymphoma in due time: a practical approach

Barth TFE, Novak U, Henz S, Schmid U, Möller P, Cogliatti SB
[Full Text]
Meeting Abstract (OP105)

Leukemia targeting ligands isolated from phage display peptide libraries

Adebahr S, Jahnke A, Jäger S, Berg T, Lübbert M, Trepel M
[Full Text]
Meeting Abstract (OP106)

Bisphosphanate activity beyond bone preservation: Direct anti-tumor effects of zoledronate

Günther A, Gordon S, Bakker F, Burger R, Tiemann M, Green JR, Rogers M, Gramatzki M
[Full Text]
Meeting Abstract (PO107)

Treatment Situation For Newly Diagnosed Multiple Myeloma (MM) Patients In Germany (GER)- First Results From A Representative Multicentre Treatment Survey

Freund M, Knauf W, Goldschmidt H, Einsele H, Nowrousian MR, Berdel WE, Poenisch W, Straka C, Kellermann L, Bammer S, Angermund R
[Full Text]
Meeting Abstract (PO108)

The oncogenic potential of the homeobox gene Cdx2 is depending on the N-terminal transactivation domain in vivo and can be antagonized by inhibition of the MAPK pathway in a mouse model of t(12;13)(p13;q12) positive AML

Rawat VPs, Arseni N, Naidu MV, Suh RE, Lynch JP, Hiddemann W, Feuring-Buske M, Buske C
[Full Text]
Meeting Abstract (PO109)

Similarities and differences of human healthy and malignant hematopoietic stem cells

Lannert H, Able T, Franz T, Bathke A, Hofmann R, Lenze A, Horsch K, Eckstein V, Saffrich R, Ho AD
[Full Text]
Meeting Abstract (PO110)

Late cardiac toxicity in Hodgkin's disease survivors after mediastinal radiotherapy: investigation using cardiac MRI

Vordermark D, Seufert I, Schwab F, Kölbl O, Kung M, Machann W, Flentje M, Angermann C, Beer M
[Full Text]
Meeting Abstract (PO111)

Fludarabine (Fludara®) ist highly effective and safe treatment of advanced CLL also in elderly and comorbid patients: Interim analysis of a quality assurance documentation in the oncological practice

Tschechne B, Luft S, Meyer D, Blumenstengel K, Däßler KU, Detken S, Marquard F, Hinrichs HF, Otremba B, Tessen HW, Ammon A, von Wussow P
[Full Text]
Meeting Abstract (PO112)

Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma

Meisinger I, Weisel K, Hartmann JT
[Full Text]
Meeting Abstract (PO113)

Bendamustine in Combination with Thalidomide and Prednisolone (BPT) in Patients with Refractory or Relapsed Multiple Myeloma: Results of a Phase I Clinical Trial

Pönisch W, Rozanski M, Goldschmidt H, Hoffmann FA, Boldt T, Ruffert U, Rohrberg R, Schwarzer A, Schwalbe E, Kreibich U, Haak U, Niederwieser D
[Full Text]
Meeting Abstract (PO114)

Role Of Bortezomib In The Treatment Of Multiple Myeloma - First Results From a Representative Multicentre Treatment Survey in Germany (GER)

Angermund R, Knauf W, Freund M, Nowrousian MR, Einsele H, Goldschmidt H, Berdel WE, Poenisch W, Straka C, Kellermann L, Bammer S
[Full Text]
Meeting Abstract (PO115)

Individualised Therapy in Geriatric Patients with Non-Hodgkin Lymphoma - Report of a Single Center

Schroeder M, Greiff U, Dastgir-Saadat T, Noack C, Schäfer U
[Full Text]
Meeting Abstract (PO116)

Inpatient rehabilitation for patients wih multiple myeloma / plasmacytoma: Rehabilitation needs and effects of an integrative program Stationäre Rehabilitation für Patienten mit Multiplem Myelom / Plasmozytom: Rehabilitationsbedarf und Effekte eine integrativen Programms

Mumm A, Weis J, Poppelreuter M, Bartsch HH
[Full Text]
Meeting Abstract (PO117)

Subcutaneous Taenia crassiceps infection in a patient with Non Hodgkin’s lymphoma with prolonged immunosuppression after fludarabine and cyclophosphamide therapy

Heldwein K, Kubin T, Tappe D, LaRegina D, Bretzel G, Löscher T, Büttner D, Biedermann HG
[Full Text]
Meeting Abstract (PO118)

Radioimmunotherapy with Y-90 labelled anti-CD45 monoclonal antibodies induces DNA-damage and activates apoptosis pathways in vivo

Friesen C, Debatin KM, Bunjes D, Reske SN
[Full Text]